Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $14.0000 (2.56%) ($13.8300 - $14.4200) on Tue. Jan. 28, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.61% (three month average) | RSI | 25 | Latest Price | $14.0000(2.56%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -0.9% a day on average for past five trading days. | Weekly Trend | ATRA declines -9.1% a week on average for past two weeks. | Market Behavior | Broad based rally for large cap. Broad based rally for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(57%) ARKG(51%) IBB(49%) IWO(49%) ARKK(48%) | Factors Impacting ATRA price | ATRA will decline at least -1.805% in a week (0% probabilities). VIXM(-37%) VXX(-36%) TLT(-12%) UNG(-7%) SHY(-1%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.805% (StdDev 3.61%) | Hourly BBV | 0 () | Intraday Trend | 1.2% | | | |
|
1 - 5 Day Possible Target | $-0.51(-103.64%) | Resistance Level | $15.72 | 5 Day Moving Average | $13.99(0.07%) | 10 Day Moving Average | $14.85(-5.72%) | 20 Day Moving Average | $15.72(-10.94%) | To recent high | -21.3% | To recent low | 28.6% | Market Cap | $1.04b | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |